Surrozen, Inc. (SRZN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Craig Parker
Employees:
171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
650-475-2820

Through selective activation of the Wnt pathway with targeted antibodies, Surrozen is pioneering a new class of therapeutics to treat serious diseases characterized by tissue injury. Surrozen is pioneering a new class of targeted regenerative antibodies to repair a broad range of tissues and restore organs damaged by serious disease. By designing tissue-specific antibodies that engage the body’s own biological repair mechanisms, we are developing a broad pipeline of first in class drug candidates to help patients across multiple disease areas of high unmet need. With pharmaceutical properties, this platform promises to overcome many of the current limitations of regenerative medicines.

Data derived from most recent annual or quarterly report
Market Cap 120.144 Million Shares Outstanding35.027 Million Avg 30-day Volume 8.728 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.51
Price to Revenue0.0 Debt to Equity0.0 EBITDA-48.837 Million
Price to Book Value1.0299 Operating Margin0.0 Enterprise Value1.435 Million
Current Ratio11.79 EPS Growth0 Quick Ratio11.4
1 Yr BETA 1.0659 52-week High/Low 14.0 / 1.98 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score1.8977 Free Cash Flow to Firm 0
Earnings Report2022-08-10
View SEC Filings from SRZN instead.

View recent insider trading info

Funds Holding SRZN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SRZN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WILLIAMS CHARLES O CHIEF FINANCIAL OFFICER

125,000 2022-03-01 1

PARKER CRAIG C CHIEF EXECUTIVE OFFICER

370,000 2022-03-01 1

VANHOVE GEERTRUI CHIEF MEDICAL OFFICER

125,000 2022-03-01 1

YEH WEN-CHEN CHIEF SCIENTIFIC OFFICER

125,000 2022-03-01 1

BLUTT MITCHELL J MD

  • Director
578,667 2020-12-01 0

CONSONANCE LIFE SCIENCES

  • Director
  • 10% Owner
578,667 2020-12-01 0

LIVINGSTON KEVIN HAROLD CHIEF FINANCIAL OFFICER

  • Officer
578,667 2020-12-01 0

SOFFER BENNY

  • Director
578,667 2020-12-01 0

SANTEL DONALD J

  • Director
0 2020-11-18 0

CONSONANCE CAPITAL MANAGEMENT LP

CONSONANCE CAPMAN GP, LLC

CONSONANCE CAPITAL OPPORTUNITY FUND MANAGEMENT LP

  • Director
0 2020-11-18 0

SOFFER GAD

  • Director
0 2020-11-18 0

HAQQ CHRISTOPHER

  • Director
0 2020-11-18 0

JARRETT JENNIFER

  • Director
0 2020-11-18 0

HOUSE JOSHUA CORY VP BUSINESS DEVELOPMENT

  • Officer
0 2020-11-18 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SURROZEN INC SRZN 2022-06-24 22:15:03 UTC -8.7391 10.3091 800000
SURROZEN INC SRZN 2022-06-24 21:45:03 UTC -8.7391 10.3091 800000
SURROZEN INC SRZN 2022-06-24 21:15:04 UTC -8.7391 10.3091 800000
SURROZEN INC SRZN 2022-06-24 20:45:03 UTC -8.7391 10.3091 800000
SURROZEN INC SRZN 2022-06-24 20:15:03 UTC -8.7391 10.3091 800000
SURROZEN INC SRZN 2022-06-24 19:45:03 UTC -8.7391 10.3091 800000
SURROZEN INC SRZN 2022-06-24 19:15:03 UTC -8.7391 10.3091 800000
SURROZEN INC SRZN 2022-06-24 18:45:03 UTC -8.7391 10.3091 800000
SURROZEN INC SRZN 2022-06-24 18:15:04 UTC -8.7391 10.3091 800000
SURROZEN INC SRZN 2022-06-24 17:45:03 UTC -8.7391 10.3091 800000
SURROZEN INC SRZN 2022-06-24 17:15:03 UTC -8.7391 10.3091 800000
SURROZEN INC SRZN 2022-06-24 16:45:03 UTC -8.6763 10.2463 800000
SURROZEN INC SRZN 2022-06-24 16:15:03 UTC -8.6763 10.2463 800000
SURROZEN INC SRZN 2022-06-24 15:45:03 UTC -8.6763 10.2463 800000
SURROZEN INC SRZN 2022-06-24 15:15:03 UTC -8.6763 10.2463 500000
SURROZEN INC SRZN 2022-06-24 14:45:03 UTC -8.6788 10.2488 500000
SURROZEN INC SRZN 2022-06-24 14:15:03 UTC -8.6788 10.2488 500000
SURROZEN INC SRZN 2022-06-24 13:45:03 UTC -8.6788 10.2488 500000
SURROZEN INC SRZN 2022-06-24 13:15:03 UTC -8.6788 10.2488 500000
SURROZEN INC SRZN 2022-06-24 12:45:03 UTC -8.6788 10.2488 500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments